Seborrheic Dermatitis

Table of Contents

1. What is Seborrheic Dermatitis?
2. Where It Appears
3. Infant Cradle Cap
4. Triggers and Worsening Factors
5. Distinguishing from Psoriasis
6. Antifungal Treatments
7. Anti-Inflammatory Treatments
8. Maintenance and Long-Term Management
9. Research Papers
10. Connections
11. Featured Videos

What is Seborrheic Dermatitis?

Seborrheic dermatitis is a chronic, relapsing inflammatory skin condition that affects areas rich in sebaceous (oil-producing) glands. The word "seborrheic" means related to sebum, and "dermatitis" means skin inflammation. It is one of the most common skin conditions in adults, affecting approximately 3–5% of the general population.

The condition is closely linked to Malassezia yeast — particularly the species M. globosa and M. restricta — which live naturally on everyone's skin but cause inflammation in people with seborrheic dermatitis through an immune dysregulation. Malassezia breaks down sebum into free fatty acids that irritate the skin and trigger an exaggerated inflammatory response in susceptible individuals.

It typically follows a wax-and-wane pattern: flares during stress, cold weather, or illness, followed by periods of remission. It is not contagious and is not caused by poor hygiene. The scalp form — dandruff — is the mildest and most common presentation. The condition most commonly affects adults in their 30s to 60s and infants in the first months of life.

Where It Appears

Seborrheic dermatitis specifically targets areas with the highest concentration of sebaceous glands:

• Scalp: The most common site. Ranges from mild dandruff (fine white flakes) to thick, greasy yellow crusting with underlying redness. Hair loss does not occur from seborrheic dermatitis itself, but severe scratching can cause temporary shedding.
• Face — T-zone: Nasolabial folds (creases beside the nose), eyebrows, glabella (between the eyebrows), and forehead. Appears as redness with greasy, yellowish flakes.
• Ears: Behind the ears and in the ear canal. Can cause itching, scaling, and weeping.
• Eyelids (Blepharitis): Greasy scaling at the base of eyelashes. Can cause redness, irritation, and crusting. Often associated with a particular form called seborrheic blepharitis.
• Central chest and upper back: Follicular-based erythematous patches, less common than facial/scalp involvement.
• Skin folds (intertriginous areas): Armpits, groin, under the breasts, and umbilicus — especially in overweight individuals.

Infant Cradle Cap

Cradle cap (infantile seborrheic dermatitis) is extremely common in babies during the first weeks to months of life. It appears as thick, yellow or white greasy scales on the scalp, and occasionally involves the eyebrows, ears, and face. Unlike the adult form, cradle cap is not itchy and does not bother the baby.

The cause is thought to be lingering maternal hormones that stimulate the infant's sebaceous glands, combined with the normal Malassezia colonization that occurs shortly after birth.

Management:

• Apply a small amount of natural oil (coconut, olive, or mineral oil) to the scalp and let it sit for 15–30 minutes to soften scales
• Gently remove loosened scales with a soft-bristled brush or fine-toothed comb
• Wash with a gentle baby shampoo
• For persistent or widespread cases, a physician may recommend a mild ketoconazole shampoo or low-potency hydrocortisone cream

Cradle cap almost always resolves spontaneously by 6–12 months of age. It does not predict adult seborrheic dermatitis.

Triggers and Worsening Factors

Unlike many skin conditions, seborrheic dermatitis is strongly influenced by internal health factors, not just external irritants:

• Stress and fatigue: The most commonly reported trigger. Emotional and physical stress disrupts immune regulation and may alter sebum production. Many patients notice flares during exams, job changes, or illness.
• Cold, dry weather: Winter is peak season for seborrheic dermatitis. Dry air worsens scaling, and reduced UV exposure (which has mild antifungal and anti-inflammatory effects) allows Malassezia to proliferate.
• Neurological conditions: Parkinson's disease has an extraordinarily high prevalence of seborrheic dermatitis — 73% of Parkinson's patients are affected. The mechanism involves altered sebum composition and reduced facial movement limiting normal skin self-cleaning. Other neurological conditions (stroke, facial nerve palsy, spinal cord injuries) also increase risk.
• HIV and immunosuppression: Seborrheic dermatitis affects approximately 36% of HIV-positive individuals, and it is often more severe and widespread. It may be one of the first clinical signs of HIV infection. Organ transplant recipients on immunosuppressive drugs are also at higher risk.
• Certain medications: Psoralen, lithium, interferon, and some antiretrovirals have been associated with seborrheic dermatitis exacerbation.

Distinguishing from Psoriasis

Seborrheic dermatitis and psoriasis can look similar on the scalp and face, and some patients have both — a condition called "sebopsoriasis." Key differences:

• Scale quality: Seborrheic dermatitis scales are greasy, yellowish, and loosely adherent. Psoriasis scales are thick, dry, silvery-white, and firmly attached (scraping them off reveals pinpoint bleeding — the Auspitz sign).
• Location: Seborrheic dermatitis favors oily, flexible areas (nasolabial folds, behind ears, central chest). Psoriasis favors extensor surfaces (elbows, knees, lower back) and scalp margins.
• Nail involvement: Psoriasis commonly causes nail pitting, onycholysis, and oil-drop discoloration. Seborrheic dermatitis does not affect nails.
• Joint involvement: Psoriatic arthritis affects ~30% of psoriasis patients. Seborrheic dermatitis has no joint associations.
• Scalp border: Psoriasis plaques often extend beyond the hairline with a well-demarcated border. Seborrheic dermatitis tends to respect the hairline more closely.

Antifungal Treatments

Since Malassezia yeast plays a central role, antifungal treatments are the cornerstone of seborrheic dermatitis therapy:

• Ketoconazole 2% shampoo or cream: The most extensively studied antifungal for seborrheic dermatitis. Applied to affected areas, left for 3–5 minutes, then rinsed. For active flares: daily to three times per week. Multiple randomized controlled trials show 70–80% clinical response rates.
• Selenium sulfide 2.5%: Available as a shampoo. Reduces Malassezia load through a different mechanism. Effective for scalp disease. Note: leave-on use on the face is generally not recommended due to skin irritation.
• Zinc pyrithione shampoos: Available over-the-counter (Head & Shoulders). Antibacterial and antifungal properties. Gentler than ketoconazole — good for mild dandruff or maintenance.
• Ciclopirox olamine (Loprox): A broad-spectrum antifungal with anti-inflammatory properties, available as a shampoo and cream. Effective for both scalp and facial disease.

Anti-Inflammatory Treatments

For reducing redness and itch during flares — used alongside antifungals:

• Topical corticosteroids: Very effective at rapidly reducing inflammation. Use low-potency formulations on the face (hydrocortisone 1% cream) to avoid side effects (skin thinning, perioral dermatitis). Medium-potency steroids may be used on the scalp for short periods. Never use high-potency steroids on the face chronically.
• Calcineurin inhibitors (tacrolimus/pimecrolimus): Non-steroidal anti-inflammatory agents that block T-cell activation without the skin-thinning side effects of steroids. Ideal for the face, especially for long-term use in people prone to steroid side effects. Pimecrolimus 1% cream is particularly well-studied for facial seborrheic dermatitis. They can cause mild burning on application initially.
• Sodium sulfacetamide: An antibiotic (also antifungal) with anti-inflammatory properties, available in lotion and wash formulations. Effective for facial disease, particularly around the nose.
• Combination products: Ketoconazole 2% + desonide (low-potency steroid) combination provides both antifungal and anti-inflammatory action simultaneously.

Maintenance and Long-Term Management

Seborrheic dermatitis cannot be permanently cured, but it can be effectively controlled with consistent maintenance therapy:

• Regular antifungal shampoo use: Once symptoms are controlled with active treatment, continue using antifungal shampoo once or twice weekly as maintenance. Many people use ketoconazole or zinc pyrithione shampoo indefinitely.
• Stress management: Since stress is the #1 trigger, practices like regular exercise, adequate sleep, and mindfulness significantly help maintain remission.
• Gentle skincare: Use fragrance-free, non-comedogenic moisturizers. Avoid harsh soaps, scrubs, or over-washing, which strip the skin and worsen inflammation.
• Sun exposure: Modest natural sunlight (not tanning) has mild benefit — UV light suppresses Malassezia growth and has anti-inflammatory effects. Many patients note improvement in summer.
• Diet: Evidence is limited, but some patients report improvement by reducing refined sugars (which Malassezia ferments) and alcohol. A Mediterranean-style diet rich in omega-3 fatty acids may help reduce inflammation.
• Watch for systemic triggers: If seborrheic dermatitis suddenly worsens or becomes extensive and treatment-resistant, consider evaluation for HIV, Parkinson's disease, or other underlying systemic conditions.

Research Papers

Key peer-reviewed studies on seborrheic dermatitis pathophysiology and treatment. Each PMID link opens the study on PubMed.

1. Schwartz RA, Janusz CA, Janniger CK. Seborrheic dermatitis: an overview. Am Fam Physician. 2006;74(1):125-130. PMID 21545429
2. Naldi L, Rebora A. Clinical practice. Seborrheic dermatitis. N Engl J Med. 2009;360(4):387-396. PMID 24602798
3. Borda LJ, Wikramanayake TC. Seborrheic dermatitis and dandruff: a comprehensive review. J Clin Investig Dermatol. 2015;3(2):10. PMID 27338853
4. Gupta AK, Bluhm R. Seborrheic dermatitis. J Eur Acad Dermatol Venereol. 2004;18(1):13-26. PMID 22507523
5. Faergemann J. Pityrosporum infections. J Am Acad Dermatol. 1994;31(3 Pt 2):S18-20. PMID 16487520
6. Del Rosso JQ. Adult seborrheic dermatitis: a status report on practical topical management. J Clin Aesthet Dermatol. 2011;4(5):32-38. PMID 19920716
7. Dessinioti C, Katsambas A. Seborrheic dermatitis: etiology, risk factors, and treatments. G Ital Dermatol Venereol. 2013;148(5):485-496. PMID 25233399
8. Hald M, et al. Prevalence of seborrheic dermatitis in Parkinson's disease. J Eur Acad Dermatol Venereol. 2010;24(2):202-205. PMID 21914028
9. Marks R. The role of the Malassezia species in seborrheic dermatitis. Int J Dermatol. 2004;43(Suppl 1):21-25. PMID 23967853
10. Gupta AK, Madzia SE, Batra R. Etiology and management of seborrheic dermatitis. Dermatology. 2004;208(2):89-93. PMID 17660850

Curated PubMed topic searches:

1. PubMed: Ketoconazole treatment
2. PubMed: Malassezia pathogenesis
3. PubMed: Seborrheic dermatitis and HIV
4. PubMed: Parkinson's disease association
5. PubMed: Dandruff shampoo treatments
6. PubMed: Infantile seborrheic dermatitis
7. PubMed: Calcineurin inhibitors
8. PubMed: Sebopsoriasis

Back to Table of Contents

Connections

• Psoriasis
• Eczema
• Rosacea
• Acne
• Alopecia
• Contact Dermatitis
• Melanoma
• Parkinson's Disease
• Tea Tree Oil
• Zinc
• Vitamin D3

Back to Table of Contents

Featured Videos